|
Market Cap (25-Jun) $80,439,416 (1,515th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 402,075 |
Shortsold (10-Feb) 29,568 (0.00%) (623rd) |
|
52w High $0.027 |
52w Low $0.003 |
P/E 4.78 |
EPS 0 |
AVE released this announcement to the ASX on 23 December 2020, 10:01. The announcement is marked as price sensitive, and is 2 page(s) in length and 192.01kb in size.
You can view all announcements from AVE and see how they appear on a price chart on the announcements page.
At the date of this announcement, AVE was 0.160% short sold according to ASIC data. It was ranked the 383rd most shorted stock on the ASX. It remains ranked 623rd as of the latest reported data (10 February 2025).
| Other Recent Announcements from AVE | |
|---|---|
| Update - Application for quotation of securities - AVE | 28 June 2023, 11:48 |
| Application for quotation of securities - AVE | 28 June 2023, 11:43 |
| AVE CBD capsule passes two-year stability milestone | 22 June 2023, 8:57 |
| AVE begins Human Trial on CBD product | 23 December 2020, 10:01 |
| Section 708A Cleansing Statement & Appendix 2A | 23 December 2020, 8:36 |
| Grant of Unlisted Options & Appendix 3G | 20 November 2020, 9:31 |
| Improved Propofol TPM Formulation Passes Toxicology Study | 4 November 2020, 8:54 |
You must be logged in to post a reply.
Avecho Biotechnology 